Signal Advisors Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Buy
1,008
+119
+13% +$44.1K 0.02% 470
2026
Q1
$260K Sell
889
-6,716
-88% -$2.21M 0.02% 510
2025
Q4
$2.67M Buy
7,605
+1,176
+18% +$397K 0.21% 96
2025
Q3
$2.08M Buy
6,429
+3,830
+147% +$1.19M 0.19% 112
2025
Q2
$1.01M Buy
2,599
+1,610
+163% +$648K 0.08% 210
2025
Q1
$430K Buy
989
+192
+24% +$77.1K 0.04% 302
2024
Q4
$294K Buy
797
+186
+30% +$77.8K 0.03% 363
2024
Q3
$318K Buy
+611
New +$326K 0.05% 341

Other funds holding ELV

Signal Advisors Wealth's ELV Position: Q2 2026 in Review

Signal Advisors Wealth increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $44.1K and bringing the position to 1,008 shares worth $390K. The position accounts for 0.02% of the portfolio, ranked #470.

Signal Advisors Wealth first reported a position in ELV in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.67M in Q4 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Signal Advisors Wealth held 1,008 shares of Elevance Health worth $390K as of Q2 2026.
  • Signal Advisors Wealth bought 119 Elevance Health shares in Q2 2026, an estimated $44.1K.
  • Elevance Health made up 0.02% of Signal Advisors Wealth's portfolio in Q2 2026, its #470 holding.
  • Signal Advisors Wealth first reported a position in Elevance Health in Q3 2024 and has held it in 8 quarters since.
  • Signal Advisors Wealth's Elevance Health position peaked at $2.67M in Q4 2025.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.